Reuters logo
Valeant CEO 'delighted' by Paulson's Allergan stake
June 26, 2014 / 4:46 PM / 3 years ago

Valeant CEO 'delighted' by Paulson's Allergan stake

June 26 (Reuters) - Valeant Pharmaceuticals Inc Chief Executive Officer Michael Pearson said on Thursday that he is “delighted” hedge fund Paulson & Co has amassed a large stake in takeover target Allergan Inc, and believes Valeant will garner enough support to trigger a special meeting of Allergan’s board.

Reuters reported exclusively on Wednesday that Paulson had built a stake in Allergan of more than 6 million shares and supports a deal between the Botox maker and Valeant.

Reporting by Rod Nickel in Winnipeg, Manitoba

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below